Navigation Links
RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders
Date:1/14/2014

d on the mRNA that controls production of this protein.

RXi's sd‑rxRNA oligonucleotides are designed for therapeutic use and have drug-like properties, such as high potency, target specificity, serum stability, reduced immune response activation, and efficient cellular uptake. These hybrid oligonucleotide molecules combine the beneficial properties of conventional RNAi and antisense technologies.  This allows sd‑rxRNAs to achieve efficient cellular uptake and potent, long-lasting intracellular activity.

About RXi Pharmaceuticals Corporation

RXi Pharmaceuticals Corporation (OTCQX: RXII) is a biotechnology company focused on discovering, developing and commercializing innovative therapies based on its proprietary, self-delivering RNAi platform. Therapeutics that use RNA interference, or "RNAi," have great  promise because of their ability to down-regulate, the expression of a specific gene that may be over-expressed in a disease condition. Building on the pioneering work of scientific founder and Nobel Laureate Dr. Craig Mello, a member of the RXi Scientific Advisory Board, RXi's first RNAi product candidate, RXI‑109, targets connective tissue growth factor (CTGF) to reduce dermal scarring (fibrosis), entered into human clinical trials in June 2012.  For more information, please visit www.rxipharma.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future expectations, including future expectations regarding our NASDAQ listing, planned and future development of RXi Pharmaceuticals Corporation's products and technologies. Forward-looking statements about expectations and development plans of RXi's products involve significant risks, and uncertainties: risks th
'/>"/>

SOURCE RXi Pharmaceuticals Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
3. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
4. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
5. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
6. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
7. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
8. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
9. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
10. Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
11. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 Research and ... "Global Cell Culture Market 2014-2018" report to their ... Cell culture is the in vitro growth of ... research, cell studies, and biopharmaceutical production. Cell culture is ... Cell culture instruments and cell culture consumables are necessary ...
(Date:7/24/2014)... PARK, Calif. , July 24, 2014 ... seven-year contract with the National Institute of Allergy and ... Health, to conduct preclinical development of potential therapies for ... of drugs to treat HIV and AIDS and the ... well as microbicides for preventing sexual transmission of HIV. ...
(Date:7/24/2014)... Dallas, Texas (PRWEB) July 24, 2014 ... China Potassium Sulphate Industry” is a professional and ... The report introduces Potassium Sulphate basic information, ... structure and industry overview. This research covers the ... well as global industry analysis covering macroeconomic environment ...
(Date:7/24/2014)... balances – 4 steps – One Recommendation: the web-based ... narrows down the mass of product choices to a ... , First, select the working environment, then enter the ... define the accuracy – it’s really that simple. Specifying ... to models that fit best with the customer’s industry ...
Breaking Biology Technology:Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4
... Beating the drum for a socialistic platitude on the ... noble in some circles, but it does not capture ... an infrastructure that can support and sustain economic development. ... infrastructure providing true broadband connectivity as a Digital Desert ...
... parade as the marketplace elephant passes by - or follow ... state Sen. Bob Jauch , the veteran Democrat from ... bill. So far, the answer isn't pretty. , ,The ... $57.7 billion budget bill sent to them by Gov. Jim ...
... Employers who wonder where their future technologists will ... high school students soon will graduate from an ... University of Wisconsin-Madison's Information Technology Academy . ... provides hands-on training and access to technology for ...
Cached Biology Technology:Bridging the digital divide is the wrong battle cry 2Bridging the digital divide is the wrong battle cry 3Bridging the digital divide is the wrong battle cry 4Legislature should look to Wisconsin's natural energy advantages 2Legislature should look to Wisconsin's natural energy advantages 3
(Date:7/24/2014)... new study has identified two factors that characterize ... the production of highly qualified physics teachers. Specifically, ... champion physics teacher education in combination with institutional ... remain viable. Science, Technology, Engineering and Math (STEM) ... the study points the way for institutions seeking ...
(Date:7/24/2014)... billion years of evolutionary trial and error, is the ... be reaching a tipping point. , In a new ... in Science , an international team of scientists ... contributing to what appears to be the early days ... Since 1500, more than 320 terrestrial vertebrates have become ...
(Date:7/24/2014)... meaning the microbial populations found on surfaces in the ... final flavor according to research published ahead of print ... This is the first time investigators have taken a ... sake makers inoculate with both bacteria and yeast, says ... California, Davis, but he and his colleagues investigated a ...
Breaking Biology News(10 mins):Creating sustainable STEM teacher preparation programs 2Stanford biologist warns of early stages of Earth's 6th mass extinction event 2Stanford biologist warns of early stages of Earth's 6th mass extinction event 3The microbes make the sake brewery 2
... found in the Chesapeake Bay and other waterways emits a ... immobilize the prey it plans to eat, a team of ... linked to massive fish kills could lead to new ways ... creatures. The researchers studied the behavior of the algal ...
... Groundbreaking work is under way to establish just how big ... The study is the first of its kind in the ... innovative measures that will cut these emissions, such as: ... with anyone,s home, reducing the need to travel to airports to ...
... A new study published in CMAJ ( ... the severity of H1N1 influenza has found that admissions ... a longer interval between symptom onset and treatment with ... People of First Nations ethnicity were also found to ...
Cached Biology News:Discovery of algae's toxic hunting habits could help curb fish kills 2Discovery of algae's toxic hunting habits could help curb fish kills 3Saying goodbye at airports the green way 2Disease severity in H1N1 patients 2
Anti-human VEGFR-1/Flt-1, clone Flt-1/EWI, Monoclonal Antibody...
100 ug affinity purified rabbit anti-JIP-1 polyclonal antibody. Reacts with mouse and rat. Perform well in Western blotting. Other applications have not been tested. Storage Temperature: -20C Shi...
...
... Neuron navigator 1 ( Abpromise for all ... peptide conjugated to KLH derived from within residues ... 1. (Note: the amino acid sequence is ... ab32208 .) Entrez Gene ID: ...
Biology Products: